A small molecule forces the protein-translation machinery to overlook the signals that would otherwise result in its premature termination. Genuine stop signs are, however, read and obeyed.
Notes
This article and the paper concerned1 were published online on 22 April 2007.
References
Welch, E. M. et al. Nature 447, 87–91 (2007).
Howard, M., Frizzell, R. A. & Bedwell, D. M. Nature Med. 2, 467–469 (1996).
Ainsworth, C. Nature 438, 726–728 (2005).
Hamed, S. A. IDrugs 9, 783–789 (2006).
Chang, Y.-F., Imam, J. S. & Wilkinson, M. F. Annu. Rev. Biochem. 76, doi:10.1146/annurev.biochem.76.050106.093909 (2007).
Ishigaki, Y., Li, X., Serin, G. & Maquat, L. E. Cell 106, 607–617 (2001).
Nagy, E. & Maquat, L. E. Trends Biochem. Sci. 23, 198–199 (1998).
Lelivelt, M. J. & Culbertson, M. R. Mol. Cell. Biol. 19, 6710–6719 (1999).
He, F. et al. Mol. Cell 12, 1439–1452 (2003).
Mendell, J. T., Sharifi, N. A., Meyers, J. L., Martinez-Murillo, F. & Dietz, H. C. Nature Genet. 36, 1073–1078 (2004).
Mitrovich, Q. M. & Anderson, P. Curr. Biol. 15, 963–967 (2005).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schmitz, A., Famulok, M. Ignore the nonsense. Nature 447, 42–43 (2007). https://doi.org/10.1038/nature05715
Published:
Issue Date:
DOI: https://doi.org/10.1038/nature05715
- Springer Nature Limited
This article is cited by
-
A small molecule that induces translational readthrough of CFTR nonsense mutations by eRF1 depletion
Nature Communications (2021)
-
PTC124 improves readthrough and increases enzymatic activity of the CPT1A R160X nonsense mutation
Journal of Inherited Metabolic Disease (2011)